Common Contracts
8 similar null contracts by Ondas Holdings Inc., ENDRA Life Sciences Inc., Hancock Jaffe Laboratories, Inc., Petra Acquisition Inc.
FORM OF WARRANTOndas Holdings Inc. • February 26th, 2024 • Radio & tv broadcasting & communications equipment • Delaware
THIS CERTIFIES THAT, for value received and subject to the terms and conditions set forth below, [●], or assigns (the “Holder”), is entitled to purchase at the Exercise Price (defined below) from Ondas Holdings Inc., a Nevada corporation (the “Company”), [●] fully-paid and non-assessable shares of Common Stock of the Company.
REVELATION BIOSCIENCES, INC. COMMON STOCK WARRANT January 31, 2021 Void After January 31, 2027Petra Acquisition Inc. • September 20th, 2021 • Blank checks • New York
THIS CERTIFIES THAT, for value received and subject to the terms and conditions set forth below, National Securities Corporation, or assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from Revelation Biosciences, Inc., a Delaware corporation (the “Company”), Sixty-One Thousand Six-Hundred (61,600) fully-paid and non-assessable shares of Common Stock of the Company. This Warrant is being issued pursuant to that certain Placement Agent Agreement by and between the National Securities Corporation and the Company, dated January 27, 2021 (the “Agreement”).
ONDAS HOLDINGS INC. FORM OF COMMON STOCK WARRANTOndas Holdings Inc. • May 7th, 2020 • Radio & tv broadcasting & communications equipment • Nevada
THIS CERTIFIES THAT, for value received and subject to the terms and conditions set forth below, [INVESTOR NAME], or assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from Ondas Holdings Inc., a Nevada corporation (the “Company”), [WARRANT SHARES] fully-paid and non-assessable shares of Common Stock of the Company. DEFINITIONS. As used herein, the following terms shall have the following respective meanings:
HANCOCK JAFFE LABORATORIES, INC. COMMON STOCK WARRANT February [___], 2020 Void After February [___], 2025Hancock Jaffe Laboratories, Inc. • March 2nd, 2020 • Surgical & medical instruments & apparatus • New York
THIS CERTIFIES THAT, for value received and subject to the terms and conditions set forth below, [ ], or assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from Hancock Jaffe Laboratories, Inc., a Delaware corporation (the “Company”), [ ][1] fully-paid and non-assessable shares of Company Common Stock. This Warrant is being issued pursuant to that certain Securities Purchase Agreement, by and between the Company and Holder and the other Buyers party thereto (the “Buyers”), dated as of February 25, 2020 (the “Agreement”).
ONDAS HOLDINGS INC. FORM OF COMMON STOCK WARRANTOndas Holdings Inc. • October 1st, 2019 • Radio & tv broadcasting & communications equipment • New York
THIS CERTIFIES THAT, for value received and subject to the terms and conditions set forth below, [● or assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from Ondas Holdings Inc., a Nevada corporation (the “Company”) [● fully-paid and non-assessable shares of Common Stock of the Company. This Warrant is being issued pursuant to that certain Securities Purchase Agreement by and among the Company, the Holder and certain other parties thereto, dated September 27, 2019 (the “Agreement”).
ONDAS HOLDINGS INC. FORM OF COMMON STOCK WARRANTOndas Holdings Inc. • October 1st, 2019 • Radio & tv broadcasting & communications equipment • New York
THIS CERTIFIES THAT, for value received and subject to the terms and conditions set forth below, National Securities Corporation, or assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from Ondas Holdings Inc., a Nevada corporation (the “Company”) [·] fully-paid and non-assessable shares of Common Stock of the Company. This Warrant is being issued pursuant to that certain Placement Agent Agreement by and between the National Securities Corporation and the Company, dated September 27, 2019 (the “Agreement”).
ENDRA LIFE SCIENCES INC. COMMON STOCK WARRANTENDRA Life Sciences Inc. • July 29th, 2019 • Electromedical & electrotherapeutic apparatus • New York
THIS CERTIFIES THAT, for value received and subject to the terms and conditions set forth below, __________, or assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), _________ fully-paid and non-assessable shares of Company Common Stock. This Warrant is being issued pursuant to that certain Securities Purchase Agreement, by and between the Company and Holder and the other Buyers party thereto (the “Buyers”), dated as of July 26, 2019 (the “Agreement”)
ENDRA LIFE SCIENCES INC. COMMON STOCK WARRANTENDRA Life Sciences Inc. • July 2nd, 2018 • Electromedical & electrotherapeutic apparatus • New York
THIS CERTIFIES THAT, for value received and subject to the terms and conditions set forth below, [_________], or assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), [_________] fully-paid and non-assessable shares of Company Common Stock. This Warrant is being issued pursuant to that certain Securities Purchase Agreement, by and between the Company and Holder and the other Buyers party thereto (the “Buyers”), dated as of June 28, 2018 (the “Agreement”)
